EANS-Adhoc: Sanacorp Pharmaholding AG
Sanacorp disposes of Anzag investment
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
18.10.2010
The pharmaceutical wholesale company Sanacorp Pharmahandel GmbH
("Sanacorp GmbH"), which is indirectly owned by Sanacorp
Pharmaholding Aktiengesellschaft via its 50 percent interest in the
Italian holding company Sanastera S.p.A., Bologna, signed an
agreement on October 18th., 2010 stipulating the sale of
approximately 24.99% in the capital stock of Andreae-Noris Zahn AG,
Frankfurt (WKN 504700/ISIN DE0005047005). Acquirer is an investment
company of the Alliance Boots Group. The implementation of the share
purchase agreement is subject to the responsible cartel authorities´
approval.The purchase price agreed per share is EUR 26.00. Sanacorp GmbH will thus receive cash flows of more than EUR 69 million expected to be used for the settlement of liabilities.
Sanacorp Pharmaholding AG
The Management Board
end of announcement euro adhoc
Further inquiry note:
Dr. Thomas Strieder
Phone: +49(89) 8581 494
E-Mail: t.strieder@sanacorp.de
Branche: Wholesale
ISIN: DE0007163131
WKN: 716313
Index: CDAX, Classic All Share
Börsen: Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / regulated dealing
Frankfurt / regulated dealing/general standard